Inhibitors of histone deacetylase
US9988343B2 · kind B2 · utility
7Cited by
0References
22Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 5, 2014 |
| Grant date | Jun 5, 2018 |
| Priority date | — |
| Expiry date | Nov 5, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D241/24
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds which inhibit histone deacetylase activity and methods of synthesizing these compounds. The present invention also relates to pharmaceutical compositions containing these compounds. The present invention also relates to methods of treating and preventing hematological cell proliferative disorders, such as multiple myeloma, by administering these compounds and pharmaceutical compositions to subjects in need thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.